Tan, Tuan Zea

Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients

Tan, T. Z., Miow, Q. H., Miki, Y., Noda, T., Mori, S., Huang, R. Y., & Thiery, J. P. (2014) · EMBO Molecular Medicine

Cancer Cells and MetastasisTGF-β signaling in diseases

Cited by 792

Dual role of autophagy in hallmarks of cancer

Singh, S. S., Vats, S., Chia, A. Y.-Q., Tan, T. Z., Deng, S., Ong, M. S., Arfuso, F., Yap, C. T., Goh, B. C., Sethi, G., et al. (2018) · Oncogene

Autophagy in Disease and TherapyUbiquitin and proteasome pathways

Cited by 542

The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200

Noman, M. Z., Janji, B., Abdou, A., Hasmim, M., Terry, S., Tan, T. Z., Mami-Chouaib, F., Thiery, J. P., & Chouaib, S. (2017) · OncoImmunology

Cancer Immunotherapy and BiomarkersCancer Cells and Metastasis

Cited by 253

Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C–Mutant Non–Small Cell Lung Cancer

Adachi, Y., Ito, K., Hayashi, Y., Kimura, R., Tan, T. Z., Yamaguchi, R., & Ebi, H. (2020) · Clinical Cancer Research

Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling

Cited by 249

Cytoskeletal dynamics in epithelial-mesenchymal transition: insights into therapeutic targets for cancer metastasis

Datta, A., Deng, S., Gopal, V., Yap, K. C.-H., Halim, C. E., Lye, M. L., Ong, M. S., Tan, T. Z., Sethi, G., Hooi, S. C., et al. (2021) · Cancers

Cancer Cells and MetastasisCellular Mechanics and Interactions

Cited by 184

TRPV4 Regulates Breast Cancer Cell Extravasation, Stiffness and Actin Cortex

Lee, W. H., Choong, L. Y., Mon, N. N., Lu, S., Lin, Q., Pang, B., Yan, B., Krishna, V. S. R., Singh, H., Tan, T. Z., et al. (2016) · Scientific Reports

Ion Channels and ReceptorsCancer Cells and Metastasis

Cited by 125

Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer

Miow, Q. H., Tan, T. Z., Ye, J., Lau, J. A., Yokomizo, T., Thiery, J.-P., & Mori, S. (2015) · Oncogene

Cancer Cells and MetastasisOvarian cancer diagnosis and treatment

Cited by 117

A Single-Cell Atlas Identifies Pretreatment Features of Primary Imatinib Resistance in Chronic Myeloid Leukemia

Krishnan, V., Schmidt, F., Nawaz, Z., Lee, K. L., Nori Venkatesh, P., Makheja, M., Chan, Z. E., Yu, M., Arul Rayan, N., Gek Liang Lim, M., et al. (2022) · Blood

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 15

Improving tractability of Clinical Decision Support system

Tan, T. Z., Ng, G. S., & Quek, C. (2008) · 2008 IEEE International Joint Conference on Neural Networks (IEEE World Congress on Computational Intelligence)

Electronic Health Records SystemsArtificial Intelligence in Healthcare and Education

Cited by 3